Literature DB >> 28868288

Uveal Melanoma with Histopathologic Intratumoral Heterogeneity Associated with Gene Expression Profile Discordance.

Audra K Miller1, Matthew J Benage2, David J Wilson1, Alison H Skalet1.   

Abstract

PURPOSE: To report a case of intratumoral gene expression profile discordance in a malignant uveal melanoma, associated with intratumoral heterogeneity based upon histopathologic features.
METHODS: The clinical history, fundus findings, imaging and histopathologic features, and DecisionDx-UM gene expression profile results (Castle Biosciences, Inc., Phoenix, AZ, USA) of the tumor were reviewed.
RESULTS: A trans-retinal fine-needle aspiration biopsy was performed for a thin, pigmented choroidal tumor in a 33-year-old man. Cells obtained from this biopsy were tested using the DecisionDx-UM gene expression profile test and the tumor was classified as class 1A. Cytology confirmed melanoma. The patient subsequently elected to undergo enucleation. On microscopic examination of the globe, the tumor was composed primarily of spindle B cells, but had a focal area composed of epithelioid cells. This portion of the tumor was subsequently tested and demonstrated a class 1B gene expression profile.
CONCLUSION: Intratumoral discordance in gene expression profile results has been described in uveal melanomas. Here we demonstrate that this discordance may be associated in some cases with intratumoral heterogeneity based upon histopathologic features.

Entities:  

Keywords:  Fine-needle aspiration biopsy; Gene expression profile testing; Tumor heterogeneity; Uveal melanoma

Year:  2016        PMID: 28868288      PMCID: PMC5566757          DOI: 10.1159/000453616

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  16 in total

1.  Sudden growth of a choroidal melanoma and multiplex ligation-dependent probe amplification findings suggesting late transformation to monosomy 3 type.

Authors:  Sonia A Callejo; Justyna Dopierala; Sarah E Coupland; Bertil Damato
Journal:  Arch Ophthalmol       Date:  2011-07

2.  Genetic heterogeneity in uveal melanoma assessed by multiplex ligation-dependent probe amplification.

Authors:  Justyna Dopierala; Bertil E Damato; Sarah L Lake; Azzam F G Taktak; Sarah E Coupland
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-19       Impact factor: 4.799

3.  Prognostic testing in uveal melanoma by transcriptomic profiling of fine needle biopsy specimens.

Authors:  Michael D Onken; Lori A Worley; Rosa M Dávila; Devron H Char; J William Harbour
Journal:  J Mol Diagn       Date:  2006-11       Impact factor: 5.568

Review 4.  Estimating prognosis for survival after treatment of choroidal melanoma.

Authors:  Bertil Damato; Antonio Eleuteri; Azzam F G Taktak; Sarah E Coupland
Journal:  Prog Retin Eye Res       Date:  2011-05-30       Impact factor: 21.198

5.  Frequency and implications of discordant gene expression profile class in posterior uveal melanomas sampled by fine needle aspiration biopsy.

Authors:  James J Augsburger; Zélia M Corrêa; Bret D Augsburger
Journal:  Am J Ophthalmol       Date:  2014-11-05       Impact factor: 5.258

6.  International Validation of the American Joint Committee on Cancer's 7th Edition Classification of Uveal Melanoma.

Authors: 
Journal:  JAMA Ophthalmol       Date:  2015-04       Impact factor: 7.389

7.  Concordant chromosome 3 results in paired choroidal melanoma biopsies and subsequent tumour resection specimens.

Authors:  Sarah E Coupland; Helen Kalirai; Vivian Ho; Sophie Thornton; Bertil E Damato; Heinrich Heimann
Journal:  Br J Ophthalmol       Date:  2015-07-23       Impact factor: 4.638

8.  Prognostic Implications of Tumor Diameter in Association With Gene Expression Profile for Uveal Melanoma.

Authors:  Scott D Walter; Daniel L Chao; William Feuer; Joyce Schiffman; Devron H Char; J William Harbour
Journal:  JAMA Ophthalmol       Date:  2016-07-01       Impact factor: 7.389

9.  Integrative genomic analysis of aneuploidy in uveal melanoma.

Authors:  Justis P Ehlers; Lori Worley; Michael D Onken; J William Harbour
Journal:  Clin Cancer Res       Date:  2008-01-01       Impact factor: 12.531

10.  Current clinical practice: differential management of uveal melanoma in the era of molecular tumor analyses.

Authors:  Thomas M Aaberg; Robert W Cook; Kristen Oelschlager; Derek Maetzold; P Kumar Rao; John O Mason
Journal:  Clin Ophthalmol       Date:  2014-12-03
View more
  5 in total

1.  Correlation of Immunocytochemistry of BRCA1-associated Protein-1 (BAP1) With Other Prognostic Markers in Uveal Melanoma.

Authors:  Ben J Glasgow; Tara A McCannel
Journal:  Am J Ophthalmol       Date:  2018-03-09       Impact factor: 5.258

2.  Comparative Cytogenetic Abnormalities in Paired Choroidal Melanoma Samples Obtained Before and After Proton Beam Irradiation by Transscleral Fine-Needle Aspiration Biopsy and Endoresection.

Authors:  Alexandre Matet; Khadija Aït Raïs; Denis Malaise; Martina Angi; Rémi Dendale; Sarah Tick; Livia Lumbroso-Le Rouic; Christine Lévy-Gabriel; Manuel Rodrigues; Gaëlle Pierron; Nathalie Cassoux
Journal:  Cancers (Basel)       Date:  2019-08-14       Impact factor: 6.639

3.  An Ensemble Method to Predict Target Genes and Pathways in Uveal Melanoma.

Authors:  Chao Wei; Lei Wang; Han Zhang
Journal:  Open Life Sci       Date:  2018-04-10       Impact factor: 0.938

4.  Eye-specific quantitative dynamic contrast-enhanced MRI analysis for patients with intraocular masses.

Authors:  Myriam G Jaarsma-Coes; Teresa A Ferreira; Petra J van Houdt; Uulke A van der Heide; Gregorius P M Luyten; Jan-Willem M Beenakker
Journal:  MAGMA       Date:  2021-10-13       Impact factor: 2.310

5.  Small High-Risk Uveal Melanomas Have a Lower Mortality Rate.

Authors:  Rumana N Hussain; Sarah E Coupland; Helen Kalirai; Azzam F G Taktak; Antonio Eleuteri; Bertil E Damato; Carl Groenewald; Heinrich Heimann
Journal:  Cancers (Basel)       Date:  2021-05-08       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.